Inventor
CHEUNG ATWOOD KIM
US13 patents
⚠️ This page may combine multiple inventors who share the name “CHEUNG ATWOOD KIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
9 patentsUS10195196B2Feb 5, 2019
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
NOVARTIS AG15 citations92
US9545404B2Jan 17, 2017
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
NOVARTIS AG16 citations91
US10758533B2Sep 1, 2020
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
NOVARTIS AG2 citations71
US11708366B2Jul 25, 2023
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
NOVARTIS AG2 citations69
US11229648B2Jan 25, 2022
1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions
NOVARTIS AG0 citations61
US12157737B2Dec 3, 2024
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
NOVARTIS AG0 citations58
US11672799B2Jun 13, 2023
1,4-disubstituted pyridazine quinolne analogs there of and methods for treating SMN-deficiency-related conditions
NOVARTIS AG0 citations50
US12084442B2Sep 10, 2024
Naphthyridinone derivatives for the treatment of a disease or disorder
NOVARTIS AG0 citations46
US12129246B1Oct 29, 2024
Hydroquinazoline derivatives for the treatment of a disease or disorder
NOVARTIS AG0 citations45
CHEUNG ATWOOD KIM
3 patentsUS8729263B2May 20, 2014
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
CHEUNG ATWOOD KIM45 citations95
US9181266B2Nov 10, 2015
2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors
CHEUNG ATWOOD KIM3 citations59
US9227982B2Jan 5, 2016
4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors
CHEUNG ATWOOD KIM1 citations48